J Liver Cancer.
2015 Sep;15(2):79-83. 10.0000/jlc.2015.15.2.79.
Radiofrequency Ablation for Hepatocellular Carcinoma
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea. psyoung0419@gmail.com
- KMID: 2198535
- DOI: http://doi.org/10.0000/jlc.2015.15.2.79
Abstract
- Radiofrequency ablation (RFA) takes an important role in management of hepatocellular carcinoma (HCC) as the most popular local therapy in the world. There are many data supporting that RFA is an excellent treatment modality for early-stage HCC with favorable treatment outcomes and minimal invasiveness. Currently, RFA extends treatement indications from unresectable early-stage HCC to intermediate-stage HCC in selected cases. Thus, with technical advances in guidance and ablation as well as devices, RFA widens its territory in the combat field against HCC.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
- Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
- Completely Ablated Hepatocellular Carcinoma by Percutaneous Radiofrequency Thermal Ablation
- Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
- Current status and future of radiofrequency ablation for hepatocellular carcinoma
